Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Aerosol Med Pulm Drug Deliv ; 32(2): 78-87, 2019 04.
Article in English | MEDLINE | ID: mdl-30526251

ABSTRACT

PURPOSE: Inhalable pulmonary delivery of isoniazid (INH) may improve the efficacy and reduce drug resistance. METHOD: INH-loaded chitosan microparticles (Cs-Mps-1-3) were prepared as an inhalable carrier for the previously prepared INH-loaded polyvinylpyrrolidone/polyitaconic acid nanoparticles (NPs) using spray-drying technique. Here, Cs-Mps-1-3 are composed of Cs: INH-loaded NPs: Free INH at w/w ratios (1:1:0), (1: 0:1), and (1:1:1), respectively. Subsequently, the prepared Cs-Mps-1-3 characterizations were studied. RESULTS: Cs-Mps-1-3 showed a spherical, smooth, positively charged surface (ζ-potential values +20.2, +28.7, and +22.6) and a size range 1.52-3.12 µm. In addition, Carr's compressibility indices of Cs-Mps-1-3 were 32.5%, 24.8%, and 28.02%, respectively. The in vitro INH released showed good correlation with first-order pattern, with predominance of the diffusion-controlled mechanism. In vitro aerodynamic deposition of Cs-MPs-3 possessed 56.81% effective fine particle fraction with lower impaction loss and device retention (10.47% and 30.9% at mouth and throat and at stage 1, respectively). The minimum inhibitory concentration of Cs-Mps-3 displayed 63-fold more inhibition effects on Mycobacterium tuberculosis than INH solution, owing to the combined effect of positively charged Cs-Mps with their facilitating bacterial cell surface binding and cellular penetration activity of NPs. CONCLUSION: The promising potential of Cs-Mps-3 as an inhalable carrier for pulmonary delivery of INH is recommended.


Subject(s)
Antitubercular Agents/administration & dosage , Chitosan/chemistry , Isoniazid/administration & dosage , Lung/metabolism , Mycobacterium tuberculosis/drug effects , Administration, Inhalation , Antitubercular Agents/pharmacokinetics , Antitubercular Agents/pharmacology , Drug Carriers/chemistry , Drug Liberation , Isoniazid/pharmacokinetics , Isoniazid/pharmacology , Microbial Sensitivity Tests , Nanogels , Particle Size , Povidone/chemistry , Succinates/chemistry , Tissue Distribution
2.
Pharm Res ; 34(9): 1872-1885, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28620888

ABSTRACT

PURPOSE: Preparation of Isoniazid (INH) loaded nanogel particles using gamma radiation as safe, simple, cheap and reproducible technique for promoting mycobacterial killing in a lower-dose system aiming in developing of drug resistance. METHODS: Polymeric pH-sensitive nanogels were prepared by gamma radiation-induced polymerization of Acrylic acid (AAc) or Itaconic acid (IA), in aqueous solution of polyvinylpyrrolidone (PVP), as template polymer. The prepared nanogels were utilized for encapsulation of INH. 31X22 factorial design was employed for optimization and exploring the effect of radiation dose (X1) (30-50kGy), ratio of PVP: acid (X2) (50:50-30:70) and type of acid (X3) on the prepared nanogel characterization RESULTS: The optimized levels of X1, X2 and X3 were (50 KGy, 30:70 and Itaconic acid, respectively), with a desirability of 0.959. In-vitro INH release rate from the prepared nanogels decreased with increasing gamma radiation doses, with the predominance of the diffusion mechanism for drug release pattern. In addition, it was perceived that the minimum inhibitory concentration (MIC) of INH loaded PVP/PIA nanogels on Mycobacteria Tuberculosis was 8 folds lower than that of INH solution. CONCLUSION: The prospective of PVP-K90/PIA was recommended as a smart candidate for delivery of INH with promising achievements against tuberculosis than free drug. Graphical abstract Mechanism of formation and loading of Isoniazid PVP/PIA nanogel.


Subject(s)
Acrylates/chemistry , Antitubercular Agents/administration & dosage , Delayed-Action Preparations/chemistry , Isoniazid/administration & dosage , Povidone/chemistry , Succinates/chemistry , Antitubercular Agents/pharmacology , Drug Liberation , Gamma Rays , Gels/chemistry , Humans , Hydrogen-Ion Concentration , Isoniazid/pharmacology , Mycobacterium tuberculosis/drug effects , Polymerization , Tuberculosis/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...